| Ticker Details |
|
Kodiak Sciences Inc
|
| IPO Date: |
October 1, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.54B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.04 | 3.78%
|
| Avg Daily Range (30 D): |
$0.99 | 4.01%
|
| Avg Daily Range (90 D): |
$0.92 | 4.18%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.46M |
| Avg Daily Volume (30 D): |
.58M |
| Avg Daily Volume (90 D): |
.72M |
| Trade Size |
| Avg Trade Size (Sh.): |
86 |
| Avg Trade Size (Sh.) (30 D): |
54 |
| Avg Trade Size (Sh.) (90 D): |
64 |
| Institutional Trades |
| Total Institutional Trades: |
1,414 |
| Avg Institutional Trade: |
$2.28M |
| Avg Institutional Trade (30 D): |
$1.86M |
| Avg Institutional Trade (90 D): |
$2.05M |
| Avg Institutional Trade Volume: |
.06M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.75M |
| Avg Closing Trade (30 D): |
$2.28M |
| Avg Closing Trade (90 D): |
$2.73M |
| Avg Closing Volume: |
66.66K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-4.12
|
$-1.16
|
|
|
Diluted EPS
|
$-4.12
|
$-1.16
|
|
|
Revenue
|
$M
|
$M
|
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-217.34M
|
$-61.46M
|
$-54.31M
|
|
Operating Income / Loss
|
$-223.11M
|
$-62.35M
|
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-125.83M
|
|
|
|
PE Ratio
|
|
|
|
|
|
|